Oxidant-induced apoptosis in human retinal pigment epithelial cells: Dependence on extracellular redox state

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 3, 2005, Pages 1054-1061

  Jiang, Shunai ^a   Moriarty Craige, Siobhan E ^a   Orr, Michael ^a   Cai, Jiyang ^a,b   Sternberg Jr , Paul ^a,b   Jones, Dean P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYSTEINE; CYSTINE; CYTOCHROME C; OXIDIZING AGENT; TERT BUTYL HYDROPEROXIDE; CASP3 PROTEIN, HUMAN; CASPASE; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; CELL COMPARTMENTALIZATION; CELL POPULATION; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NERVE CELL CULTURE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; ADULT; AGED; CELL CULTURE; CELL MEMBRANE POTENTIAL; DRUG EFFECT; EXTRACELLULAR SPACE; METABOLISM; MITOCHONDRION; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELLS, CULTURED; CYSTEINE; CYSTINE; CYTOCHROMES C; EXTRACELLULAR SPACE; FAS LIGAND PROTEIN; HUMANS; IN SITU NICK-END LABELING; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIALS; MITOCHONDRIA; OXIDATION-REDUCTION; PIGMENT EPITHELIUM OF EYE; TERT-BUTYLHYDROPEROXIDE;

EID: 16244422028     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0949     Document Type: Article

References (45)

1. Deneke SM. Thiol-based antioxidants. Curr Top Cell Regul. 2000; 36:151-180.
2. Kirlin WG, Cai J, Thompson SA, et al. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med. 1999;27:1208-1218.
3. Jones DP, Carlson JL, Mody VC, et al. Redox state of glutathione in human plasma. Free Radic Biol Med 2000;28:625-635.
4. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989;2: 1294-1298.
5. Roum JH, Buhl R, McElvaney NG, et al. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol. 1993;75:2419-2424.
6. Samiec PS, Drews-Botsch C, Flagg EW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699-704.
7. Bains JS, Shaw CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev. 1997;25:335-358.
8. Mates JM, Perez-Gomez C, Nunez de Castro I, et al. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol. 2002;34:439-458.
9. Hall AG. Review: the role of glutathione in the regulation of apoptosis. Eur J Clin Invest. 1999;29:238-245.
10. Di Mascio P, Murphy ME, Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr. 1991;53:194S-200S.
11. Sen CK. Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul. 2000;36:1-30.
12. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30:1191-1212.
13. Moran LK, Gutteridge JM, Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem. 2001;8:763-772.
14. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal. 1999;11:1-14.
15. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571-573.
16. Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
17. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992; 110:1701-1708.
18. Age-Related Eye Disease study group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-1452.
19. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31:291-306.
20. Ishibashi T, Sorgente N, Patterson R, et al. Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci. 1986;27:184-193.
21. Dunaief JL, Dentchev T, Ying GS, et al. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120: 1435-1442.
22. Cai J, Nelson KC, Wu M, et al. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-221.
23. Alder VA, Cringle SJ. The effect of the retinal circulation on vitreal oxygen tension. Curr Eye Res. 1985;4:121-129.
24. Rozanowska M, Jarvis-Evans J, Korytowski W, et al. Blue light-induced reactivity of retinal age pigment: in vitro generation of oxygen-reactive species. J Biol Chem. 1995;270:18825-18830.
25. Sternberg P Jr, Davidson PC, Jones DP, et al. Protection of retinal pigment epithelium from oxidative injury by glutathione and precursors. Invest Ophthalmol Vis Sci. 1993;34:3661-3668.
26. Jones DP, Mody VC Jr, Carlson JL, et al. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med. 2002;33: 1290-1300.
27. Jiang S, Wu MW, Sternberg P, et al. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. Invest Ophthalmol Vis Sci. 2000;41:645-655.
28. Jiang S, Moriarty SE, Grossniklaus H, et al. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:2546-2553.
29. Cai J, Wu M, Nelson KC, et al. Oxidant-induced apoptosis in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1999;40:959-966.
30. Chinnaiyan AM, Dixit VM. Portrait of an executioner: the molecular mechanism of FAS/APO-1-induced apoptosis. Semin Immunol. 1997;9:69-76.
31. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta. 1995;1241:139-176.
32. Kantrow SP, Piantadosi CA. Release of cytochrome c from liver mitochondria during permeability transition. Biochem Biophys Res Commun. 1997;232:669-671.
33. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 281:1309-1312.
34. Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp 60 and Hsp 10 in the mitochondrial fraction of Jurkat cells. EMBO J. 1999;18:2040-2048.
35. Cai J, Jones DP. Superoxide in apoptosis: mitochondrial generation triggered by cytochrome c loss. J Biol Chem. 1998;273:11401-11404.
36. Jonas CR, Ziegler TR, Gu LH, et al. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic Biol Med. 2002;33:1499-1506.
37. Birkenkamp KU, Coffer PJ. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 2003;31:292-297.
38. Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003;73:689-701.
39. Naisbitt DJ, Vilar FJ, Stalford AC, et al. Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection. AIDS Res Hum Retroviruses. 2000;16:1929-1938.
40. Moriarty SE, Shah JH, Lynn M, et al. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med. 2003;35:1582-1588.
41. Jonas CR, Puckett AB, Jones DP, et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr. 2000;72:181-189.
42. Andersson A, Hutlberg B, Lindgren A. Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis. 2000;151:535-539.
43. Nkabyo YS, Ziegler TR, Gu LH, et al. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol. 2002;283:G1352-G1359.
44. Watson WH, Chen Y, Jones DP. Redox state of glutathione and thioredoxin in differentiation and apoptosis. Biofactors. 2003;17: 307-314.
45. Honda JT, Farbound B, Hjelmeland LM, Handa JT. Induction of an aging mRNA retinal pigment epithelial cell phenotype by matrix-containing advanced glycation end products in vitro. Invest Ophthalmol Vis Sci. 2001;42:2419-2425.